Datopotamab deruxtecan Antibody
Datopotamab deruxtecan is a TROP2-directed antibody-drug conjugate (ADC) demonstrating potent antitumor activity. It exhibits antibody-dependent cellular cytotoxicity in vitro and effectively suppresses tumor growth in xenograft models, supporting its research in oncology for both in vitro and in vivo experimental applications.
Product Specifications
Product Name Alternative
AntibodyDrug Conjugates (ADCs), Antibody-Drug Conjugates (ADCs), Antibody-Drug Conjugates, AntibodyDrugConjugates (ADCs), AntibodyDrugConjugates, ADCs, Dato-DXd, Datopotamab deruxtecan, DS1062, DS-1062, DS 1062, S-1062a, Topoisomerase
Target
Antibody-Drug Conjugates (ADCs), Topoisomerase, TROP2
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation, Molecular Biology
Concentration
9.61 mg/mL
Purity
95.64% (May vary between batches)
Molecular Weight
145.16 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
